Skip to main content

Table 1 Clinical and demographic characteristics of the study population

From: Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency

Variable

PLWH (n = 643)

Age, years, median (IQR)

52 (46, 61)

Sex (male), n (%)

557 (87)

Scandinavian or other European origin, n (%)

562 (87)

BMI (kg/m2), median (IQR)

25 (23, 27)

 Underweight, BMI < 18.5, n (%)

13 (2)

 Normal weight, BMI 18.5-24.99, n (%)

319 (50)

 Overweight, BMI25-29.99, n (%)

234 (36)

 Obese, BMI ≥ 30, n (%)

77 (12)

Abdominal obesity, n (%)

372 (58)

Smoking status

 Current, n (%)

154 (24)

 Previous, n (%)

218 (34)

 Never, n (%)

266 (41)

Hypertension, yes, n (%)

317 (49)

Transmission mode

 MSM, n (%)

461 (72)

 Heterosexual, n (%)

140 (22)

 IDU, n (%)

5 (0.8)

 Other, n (%)

10 (1.6)

Current CD4+, cells/µL, median (IQR)

660 (515, 831)

 < 200

10 (1.6)

 200–349

25 (4)

 350–499

101 (16)

 ≥ 500

467 (73)

CD4+ nadir < 200, cells/µL, n (%)

252 (39)

CD4+/CD8+ ratio, median (IQR)

0.9 (0.6, 1.2)

Time since HIV diagnosis, years, median (IQR)

16 (9, 24)

History of AIDS (yes), n (%)

111 (17)

Time with ART treatment, years, median (IQR)

13 (7, 20)

Exposure to older generation ART, yes, n (%)

337 (52)

  1. Hypertension was defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg and/or antihypertensive treatment
  2. MSM: men who have sex with men; IDU: injecting drug use; ART: combined antiretroviral therapy